Map Unavailable

Date(s) - 17/12/2020
9:00 am - 4:30 pm

Venue: Online Event

Registration:  |  ZOOM Link:


Which are the boundaries of healthcare and clinical research? 

Clinical research involves studies of new drugs and interventions, in which patient subjects, volunteer, to receive a new or standard treatment for a predefined period of time and provide their outcomes for evaluation, under a strict, ethically cleared, protocol process. On the other hand, the healthcare sector provides medical services to patients on regular or acute follow-up visits. Both sectors are facing major disruptions due to the increasing need for several reasons to offer virtual services. And this is where Digital Therapeutic comes in, as the new kid on the block, to promise continuous monitoring of patients and offer digital therapeutics instead of standard therapeutic methods or as an addon. 

A patient receiving standard of medical care treatment or a new promising treatment and has his outcomes constantly evaluated, is he not receiving medical care by a healthcare professional? Knowledge and insights coming from evaluation of treatments is becoming a necessity in both sectors and it has given birth to a new DTx era consuming insights to offer treatment.

In the previous editions of the iSprint workshops, we have addressed in #Sprint3 how AI mechanics are applied in the clinical research domain and in #Sprint2 the regulatory challenges of eHealth solutions seen as medical devices for clinical care. This year’s Sprint workshop will focus on how to bridge the silos of Clinical Research & eHealth and the emerging Digital Therapeutics, with a  common goal: to offer patient-centric treatments of high efficacy. For this purpose, speakers from the medical and clinical industry, as well as regulators and policy makers will present their views, on how these domains are coming closer together.


09.30 Welcome notes by Sofoklis Kyriazakos, CEO, Innovation Sprint

09.45 Vincenzo Bartoli, Senior VP, AstraZeneca“Why the patients’ digital experience will drive the next wave of innovation in pharma”

10.15 Michelle Longmire, CEO, MEDABLEVirtual Clinical Trials”

10.30 Simon Bourne, CEO, my mHealth Ltd“myCOPD the world’s first Digital Therapeutic for patients with Chronic Obstructive Pulmonary Disease”

Track I – Clinical Research & Digital Biotech

11.00 Konstantina Kostopoulou, Chief Product Officer, Innovation SprintHealthentia Digital Biotech” 

11.20 Olivier Schmidt, VP Sales Life Science, KEYRUS“Leveraging Digital – Empathic Patient Experience within Clinical Trials

11.40 Alan Yeomans, New Technologies WG leader, EUCROF‟The EUCROF New Technologies Working Group”

12.00 David Coman, CEO, Science 37‟Increasing Patient Access: The Rise of Decentralized Clinical Trials”

12.20 Kuldeep Singh Rajput, CEO, Biofourmis

12.40 Aristodemos Pnevmatikakis, Innovation Sprint and Harm op den Akker, RRD‟Hackathon Announcement”

13.10 Lunch

Track II – eHealth / DTx

14.00 Hermie Hermens, Full Professor, University of Twente – “Techmed eHealth House and the ecosystem for personalised health”

14.20 Giuseppe Recchia, CEO, daVinci Digital TherapeuticsDigital Therapies – overcoming barriers to entry into medical practice”

14.40 Alexander Olbrechts, Business Group Leader Health Tech, mHealthBELGIUΜ“mHealthBelgium, an introduction to mobile health apps in Belgium”

15.00 vCare – clinical context, Massimo Caprino, Physician, CCPThe vCARE experience: a digital coach to enhance home rehabilitation”

15.15 vCare – eHealth / REHABILITY, Lucia Pannese, CEO, Imaginary“REHABILITY: Gamifying Tele-Rehabilitation”

Panel discussion: Bridging the Silos

15.20 Moderator: Alfredo Cesario Medical Director, Co-founder, Innovation Sprint

16.00 End of workshop